Insmed Inc (NAS:INSM)
$ 25.97 -0.41 (-1.55%) Market Cap: 3.86 Bil Enterprise Value: 4.28 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 74/100

Insmed Inc at Credit Suisse Healthcare Conference - Scottsdale Transcript

Nov 12, 2019 / 05:20PM GMT
Release Date Price: $18.99 (+0.37%)
Martin Douglas Auster;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

Okay. Hey, everybody. I'm Marty Auster, SMID cap biotech analyst here at Crédit Suisse. Welcome to our session with Will Lewis, President and CEO of Insmed.

Will, we're going to talk about a lot of topics. Most of them are going to be NTM, MAC and ARIKAYCE related, but thanks for coming.

Questions & Answers

Martin Douglas Auster;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

And maybe if you want to just kind of make a -- just a brief kind of statement to catch us up on kind of what's happened in '19, and kind of what you're proud of, what you're looking forward to in 2020 and beyond and I have a bunch of specific -- more specific questions to dig into probably from there.

William H. Lewis
Insmed Incorporated - President, CEO & Chairman

Thanks very much. I think 2019 can best be summarized as just an outstanding first year of our product launch,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot